课题基金 / 基金详情

Diagnostic and Prognostic Relevance of Acute Kidney Injury Biomarkers in the ICU

Diagnostic and Prognostic Relevance of Acute Kidney Injury Biomarkers in the ICU
ICU 急性肾损伤生物标志物的诊断和预后相关性
批准号:
8303228
负责人:
Edward D Siew
金额:
$17.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2014-07-31

项目摘要

项目成果

Edward D Siew的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请者提供):以患者为导向的导师研究职业发展奖(K23)将使Edward D.Siew博士发展成为急性肾损伤(AKI)临床和转化性研究的独立研究员,并建立专注于危重疾病相关肾损伤的独立研究计划。通过提供精心设计的临床蛋白质组学、高级流行病学和生物统计学教学活动计划;本地和国际专家的密集指导;以及在设计、实施和解释来自一大批危重成年人的预期数据方面的直接经验,肖博士将利用这一奖项成为AKI研究领域一名训练有素的研究员。这一建议的主要科学目的是检验损伤的生物标志物对危重患者AKI的早期检测和预后的独立和相加的影响,并应用新兴的蛋白质组学技术来发现能够在早期诊断时预测损伤进展的新的蛋白质标志物。尽管在提供护理方面取得了进展,但AKI在危重病人中仍然是一种常见的破坏性事件,是发病率和死亡率的独立预测指标。将有希望的干预措施转化为改善AKI结果的尝试有限,为时已晚,而且不可靠的损伤标志物(即血清肌酐和尿量的变化)几乎没有提供关于持续损伤的时间和机制的信息。这些限制在混合ICU患者群体中进一步放大,在那里损伤的时间和程度更难确定。使用大量的、表型良好的重症成人前瞻性队列(急性肺损伤诊断生物标记物的有效性/有效性研究),这项建议将检验这样的假设,即由肾脏损伤的特定指标组成的生物标记物小组将对混合成人ICU人群中的AKI的早期诊断和预后具有独立和相加的价值(特定目标1a和1b)。候选人将学习应用新的蛋白质组学技术,如LC-MS-MS(LC-MS-MS),以发现和验证新的潜在蛋白质靶点,能够在AKI初始诊断时预测损伤的进展(特定目标2)。拟议的研究计划将进一步确定有希望的候选标记物在提供额外的病理生理学洞察力、增强风险分层和促进临床试验登记方面的作用。此外,这项提案中包括的研究还将为这位候选人提供技能和经验,使其能够发展成为一名成功的独立调查者,能够为改善对这种疾病患者的护理做出重大贡献。
英文摘要
DESCRIPTION (provided by applicant): The Mentored Patient-Oriented Research Career Development Award (K23) will enable Dr. Edward D. Siew to develop into an independent investigator in the clinical and translational study of acute kidney injury (AKI) and establish an independent research program focused on critical illness-associated kidney injury. Through the availability of a carefully constructed program of didactic activities in clinical proteomics, advanced epidemiology, and biostatistics; intensive mentorship by local and international experts; and direct experience in the design, implementation, and interpretation of data derived from a large prospective cohort of critically ill adults, Dr. Siew will use this award to become a highly trained investigator in AKI research. The primary scientific aims of this proposal are to examine the independent and additive impact of biological markers of injury for the early detection and prognosis of AKI in the critically ill and to apply emerging proteomic technology towards the discovery of novel protein markers able to predict progression of injury at the time of early diagnosis. Despite advances in the provision of care, AKI remains a common and devastating occurrence in the critically ill and an independent predictor of morbidity and mortality. Attempts at translating promising interventions into improved outcomes in AKI have been limited belated and unreliable markers of injury (i.e. changes in serum creatinine and urine output) that provide little information on the timing and mechanisms of ongoing injury. These limitations are further magnified in a mixed ICU patient population where the timing and extent of injury is more difficult to define. Using a large, well- phenotyped prospective cohort of critically ill adults (The Validation of Biomarkers for Acute Lung Injury Diagnosis/VALID Study), this proposal will test the hypothesis that a biomarker panel consisting of specific indicators of kidney injury will have independent and additive value for the early diagnosis and prognosis of AKI in a mixed adult ICU population (Specific Aims 1a and 1b). The candidate will learn to apply emerging proteomic techniques such as liquid- chromatography tandem mass-spectrometry (LC-MS-MS) towards discovering and verifying new potential protein targets able to predict progression of injury at the time of initial AKI diagnosis (Specific Aim 2). The proposed research plan will further define the role of promising candidate markers in providing additional pathophysiologic insight, enhancing risk stratification, and facilitating clinical trial enrollment. Further, the research included in this proposal will also provide this candidate with the skill set and experience to develop into a successful independent investigator able to make significant contributions toward improving the care of patients with this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Safety and Quality of Care Among Veterans Following Acute Kidney Injury
  • 批准号:
    10176246
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Edward D Siew
  • 依托单位:
Improving Safety and Quality of Care Among Veterans Following Acute Kidney Injury
  • 批准号:
    8866652
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Edward D Siew
  • 依托单位:
Improving Safety and Quality of Care Among Veterans Following Acute Kidney Injury
  • 批准号:
    10176181
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Edward D Siew
  • 依托单位:
Improving Safety and Quality of Care Among Veterans Following Acute Kidney Injury
  • 批准号:
    9145498
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Edward D Siew
  • 依托单位:
海外基金